Literature DB >> 11821402

Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts.

Yangmi Lim1, Innoc Han, Ho Jeong Kwon, Eok-Soo Oh.   

Abstract

To elucidate the role of focal adhesion kinase (pp125FAK) in transformation, its phosphorylation in transformed fibroblasts was compared with that of detransformed fibroblasts induced by a histone deacetylase inhibitor, trichostatin A (TSA). Inhibition of histone deacetylase activity in two different ras-transformed fibroblast lines by TSA induced a morphological change into a flattened and more spread morphology, implying detransformation. These morphological changes included increased spreading ability of transformed NIH 3T3 cells on fibronectin. Of the six tyrosine phosphorylation sites in pp125FAK, phosphorylation at position 861 (Tyr-861) was clearly decreased during detransformation by TSA. It resulted from decreased activity of Src family tyrosine kinase and/or decreased amount of Src kinase interacting with pp125FAK. Furthermore, phosphorylation of Tyr-861 was reduced substantially by the Src family kinase inhibitor, PP1, while overexpression of Src kinase increased its phosphorylation, implying that Src kinase regulates phosphorylation of pp125FAK at Tyr-861. All of these findings suggest that increased phosphorylation of pp125FAK at Tyr-861 correlates with Ras-induced transformation of fibroblasts, and TSA is able to detransform them through regulation of pp125FAK phosphorylation at Tyr-861 by an Src family kinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821402     DOI: 10.1074/jbc.M111011200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation.

Authors:  Brigitte Bourachot; Moshe Yaniv; Christian Muchardt
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 2.  Human endometrial cytodifferentiation by histone deacetylase inhibitors.

Authors:  Hiroshi Uchida; Tetsuo Maruyama; Takashi Nagashima; Masanori Ono; Hirotaka Masuda; Toru Arase; Ikuko Sugiura; Maki Onouchi; Takashi Kajitani; Hironori Asada; Yasunori Yoshimura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

Review 3.  Histone acetylation in reproductive organs: Significance of histone deacetylase inhibitors in gene transcription.

Authors:  Hiroshi Uchida; Tetsuo Maruyama; Toru Arase; Masanori Ono; Takashi Nagashima; Hirotaka Masuda; Hironori Asada; Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2005-05-03

Review 4.  New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells.

Authors:  Innoc Han; Haein Park; Eok-Soo Oh
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

5.  Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha.

Authors:  Eunyoung Keum; Yeonhee Kim; Jungyean Kim; Soojin Kwon; Yangmi Lim; Innoc Han; Eok-Soo Oh
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

6.  C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo.

Authors:  Q-y Zhu; Z Wang; C Ji; L Cheng; Y-l Yang; J Ren; Y-h Jin; Q-j Wang; X-j Gu; Z-g Bi; G Hu; Y Yang
Journal:  Cell Death Dis       Date:  2011-01-27       Impact factor: 8.469

7.  MicroExonator enables systematic discovery and quantification of microexons across mouse embryonic development.

Authors:  Guillermo E Parada; Roberto Munita; Ilias Georgakopoulos-Soares; Hugo J R Fernandes; Veronika R Kedlian; Emmanouil Metzakopian; Maria Estela Andres; Eric A Miska; Martin Hemberg
Journal:  Genome Biol       Date:  2021-01-22       Impact factor: 13.583

8.  Matrine activates PTEN to induce growth inhibition and apoptosis in V600EBRAF harboring melanoma cells.

Authors:  Hui Jin; Yu Sun; Shuiying Wang; Xiaodong Cheng
Journal:  Int J Mol Sci       Date:  2013-07-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.